Loading...
Illumina, Inc.
ILMN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$106.66
$-2.05(-1.89%)
Illumina, Inc. (ILMN) Financial Performance & Income Statement Overview
Review Illumina, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.93%
↓ 2.93%
Operating Income Growth
22.08%
↑ 22.08%
Net Income Growth
-5.34%
↓ 5.34%
Operating Cash Flow Growth
75.10%
↑ 75.10%
Operating Margin
36.06%
↑ 36.06%
Gross Margin
66.34%
↑ 66.34%
Net Profit Margin
-22.25%
↓ 22.25%
ROE
-46.49%
↓ 46.49%
ROIC
32.98%
↑ 32.98%
Illumina, Inc. (ILMN) Income Statement & Financial Overview
Review Illumina, Inc.'s (ILMN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.04B | $1.10B | $1.08B | $1.11B |
| Cost of Revenue | $358.00M | $376.00M | $335.00M | $391.00M |
| Gross Profit | $683.00M | $728.00M | $745.00M | $721.00M |
| Gross Profit Ratio | $0.66 | $0.66 | $0.69 | $0.65 |
| R&D Expenses | $252.00M | $253.00M | $253.00M | $325.00M |
| SG&A Expenses | $267.00M | $279.00M | $239.00M | -$88.00M |
| Operating Expenses | $519.00M | $553.00M | $492.00M | $237.00M |
| Total Costs & Expenses | $877.00M | $911.00M | $827.00M | $628.00M |
| Interest Income | $11.00M | $10.00M | $11.00M | $13.00M |
| Interest Expense | $25.00M | $25.00M | $36.00M | $20.00M |
| Depreciation & Amortization | $69.00M | $71.00M | $70.00M | $105.00M |
| EBITDA | $276.00M | $284.00M | $826.00M | -$1.85B |
| EBITDA Ratio | $0.27 | $0.26 | $0.76 | -$1.66 |
| Operating Income | $164.00M | $175.00M | $741.00M | $484.00M |
| Operating Income Ratio | $0.16 | $0.16 | $0.69 | $0.44 |
| Other Income/Expenses (Net) | $18.00M | $13.00M | -$21.00M | -$339.00M |
| Income Before Tax | $182.00M | $188.00M | $720.00M | -$1.98B |
| Income Before Tax Ratio | $0.17 | $0.17 | $0.67 | -$1.78 |
| Income Tax Expense | $51.00M | $1.00M | $15.00M | $12.00M |
| Net Income | $131.00M | $187.00M | $705.00M | -$1.99B |
| Net Income Ratio | $0.13 | $0.17 | $0.65 | -$1.79 |
| EPS | $0.83 | $1.18 | $4.43 | -$12.50 |
| Diluted EPS | $0.82 | $1.17 | $4.41 | -$12.50 |
| Weighted Avg Shares Outstanding | $159.00M | $159.00M | $159.00M | $159.00M |
| Weighted Avg Shares Outstanding (Diluted) | $159.00M | $160.00M | $160.00M | $159.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan